Clinical trial
Identification of Risk Factors and Development of an Interpretable Machine Learning Model for Predicting Insulin Resistance in Patients With Psoriasis
NCT07321288 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Risk Factors and Development of an Interpretable Machine Learning Model for Predicting Insulin Resistance in Patients With Psoriasis
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 1, 2025
- Completion date
- September 1, 2026
- Enrollment
- 1,265 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.